Connection
Amit Jain to Rifampin
This is a "connection" page, showing publications Amit Jain has written about Rifampin.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.264 |
|
|
|
-
Jain P, Singh U, Kumar V, Ratnam R, Jain A. Agreement between CBNAAT, liquid culture and line probe assay for detection of Mycobacterium tuberculosis and anti-tubercular drug resistance in extrapulmonary samples. Indian J Med Microbiol. 2022 Jul-Sep; 40(3):365-369.
Score: 0.209
-
Maurya S, Jain A, Rehman MT, Hakamy A, Bantun F, AlAjmi MF, Singh V, Zehra A, Khan F, Haque S, Mishra BN. In Silico Identification of Novel Derivatives of Rifampicin Targeting Ribonuclease VapC2 of M. tuberculosis H37Rv: Rifampicin Derivatives Target VapC2 of Mtb H37Rv. Molecules. 2023 Feb 08; 28(4).
Score: 0.055